Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2005

Verma S, Frambach GE, Seilstad KH, Nuovo G, Porcu P, Magro CM. Epstein--Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin. J Cutan Pathol. 2005;32(7):474-83.

Ogino S, Meyerhardt JA, Cantor M, Brahmandam M, Clark JW, Namgyal C, et al. Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer. Clin Cancer Res. 2005;11(18):6650-6.

Zhou P. Targeted protein degradation. Curr Opin Chem Biol. 2005;9(1):51-5.

Sboner A, Aliferis CF. Modeling clinical judgment and implicit guideline compliance in the diagnosis of melanomas using machine learning. AMIA Annu Symp Proc. 2005:664-8.

Febbo PG, Richie JP, George DJ, Loda M, Manola J, Shankar S, et al. Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer. Clin Cancer Res. 2005;11(14):5233-40.

Ross P, Magro CM. Clonal light chain restricted primary intrapulmonary nodular amyloidosis. Ann Thorac Surg. 2005;80(1):344-7.

Da Wu K-, Cho YS, Katz J, Ponomarev V, Chen-Kiang S, Danishefsky SJ, et al. Investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo. Proc Natl Acad Sci U S A. 2005;102(30):10640-5.

Muthukumar T, Dadhania D, Ding R, Snopkowski C, Naqvi R, Lee JB, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med. 2005;353(22):2342-51.

Neelapu SS, Gause BL, Nikcevich DA, Schuster SJ, Winter J, Gockerman JP, et al. Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim report. Clin Lymphoma. 2005;6(1):61-4.

Inghirami G, Chiarle R, Simmons WJ, Piva R, Schlessinger K, Levy DE. New and old functions of STAT3: a pivotal target for individualized treatment of cancer. Cell Cycle. 2005;4(9):1131-3.